2.920USD-6.41%Mkt Cap: 200.41M USDP/E: —Last update: 2026-06-01
Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-tech…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap200.41M USD
Enterprise Value174.86M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-35.92M USD
Revenue/Share—
Last Price2.920 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.37
EPS (TTM)-0.36
EPS (Forward)—
52W Range
1.08123% of range9.080
52W High9.080 USD
52W Low1.081 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-9.03%
ROA-6.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.13M USD
CapEx (TTM)77.57M USD
FCF Margin—
FCF Yield-16.43%
Net Debt-41.53M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio37.75
Quick Ratio36.39
Book Value/Sh8.292 USD
Cash/Share0.5950 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateMay 28, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.69.80M
Float61.26M
Insiders19.21%
Institutions18.29%
Short Interest
Short Ratio5.9d
Short % Float4.69%
Short % Out.4.55%
Shares Short3.18M
Short (prev mo.)3.61M
Technical
SMA 503.306 (-11.7%)
SMA 2003.377 (-13.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)499.02K
Avg Vol (10d)522.98K
Technical Indicators
RSI (14)43.7
MACD-0.0413
MACD Signal-0.0269
MACD Hist.-0.0144
BB Upper3.663 USD
BB Middle3.279 USD
BB Lower2.896 USD
BB Width23.38%
ATR (14)0.2554 USD
Vol Ratio (20d)1.40x